ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression

Affiliations

Free article

Comment

Mitchell D Creinin. Obstet Gynecol. 2022.

Free article

. 2022 Dec 1;140(6):1079-1080.

doi: 10.1097/AOG.0000000000005007.

No abstract available

Comment on

General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.
American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology. American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology. Obstet Gynecol. 2022 Sep 1;140(3):528-541. doi: 10.1097/AOG.0000000000004899. Obstet Gynecol. 2022. PMID: 36356248

1. General approaches to medical management of menstrual suppression. ACOG Clinical Consensus No. 3. American College of Obstetricians and Gynecologists. Obstet Gynecol 2022;140:528–41. doi: 10.1097/AOG.0000000000004899 - DOI
1. Creinin MD, Vieira CS, Westhoff CL, Mansour DJA. Recommendations for standardization of bleeding data analyses in contraceptive studies. Contraception 2022;112:14–22. doi: 10.1016/j.contraception.2022.05.011 - DOI
1. Chen BA, Eisenberg DL, Schreiber CA, Turok DK, Olariu AI, Creinin MD. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Am J Obstet Gynecol 2020;222:S888.e1–6. doi: 10.1016/j.ajog.2019.11.1288 - DOI
1. Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use. Contraception 2018;97:210–4. doi: 10.1016/j.contraception.2017.10.005 - DOI
1. Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 2008;13(suppl 1):13–28. doi: 10.1080/13625180801959931 - DOI